The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases

Abstract

Get full access to this article

View all access options for this article.

References

Turan

. The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease. Angiology. 2019;71(1):77–82.

Mantovani

Ballestri

Lonardo

Targher

. Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease. Dig Dis Sci. 2016;61(5):1246–67.

Hung

Lin

et al. The prognostic role of QTc interval in acute myocarditis. Acta Cardiol Sin. 2016;32(2):223–30.

Amsterdam

Wenger

Brindis

et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354–94.

Neumann

Sousa-Uva

Ahlsson

et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.

Farooq

van Klaveren

Steyerberg

et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013;381(9867):639–50.

Authors/Task Force Members, Windecker

Kolh

Alfonso

et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–619.